Myriad Genetics was handed a win a few weeks ago when a federal appeals court ruled in the company's favor and upheld its BRCA gene patents. However, the court also struck down Myriad's methods patents. So now, both sides — Myriad and the plaintiffs represented by the ACLU — are asking the court to review its decision, though for different reasons, says Genomics Law Report's John Conley.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A University of California, Los Angeles-led team has found turning off the CCR5 gene could improve recovery after a stroke, according to Scientific American.

South Dakota lawmakers are to weigh a bill aimed at teaching the strengths and weaknesses of scientific concepts, the Associated Press and KEVN-Black Hills Fox report.

In Science this week: the synthetic genetic system hachimoji, and more.

Thermo Fisher Scientific says it will no longer sell machines in China's Xinjiang region, according to the Wall Street Journal.